AKESO 09926.HK (AKESO) Stock Price Today—Real Time Charts and Quotes

Q: What's the stock price of AKESO 09926.HK (AKESO) today?

AKESO 09926.HK (AKESO) is currently trading at $91, with a 24h change of +0.38%. The 52-week trading range is $80.2–$159.8.

Q: What are the 52-week high and low prices for AKESO 09926.HK (AKESO)?

AKESO has a 52-week high of $159.8 and a 52-week low of $80.2, with the current price at $91.

Q: What is the price-to-earnings (P/E) ratio of AKESO 09926.HK (AKESO)? What does it indicate?

The current P/E ratio (TTM) of AKESO is -67.638, indicating how much investors pay for each dollar of earnings. A higher P/E ratio often reflects stronger growth expectations, while a lower P/E ratio may suggest a more attractive valuation or slower growth. Comparing it with the average P/E of the -- industry for a better context.

Q: What is the market cap of AKESO 09926.HK (AKESO)?

AKESO 09926.HK (AKESO) currently has a market cap of approximately $83.36B.

Q: What is the most recent quarterly earnings per share (EPS) for AKESO 09926.HK (AKESO)?

AKESO 09926.HK (AKESO)'s diluted earnings per share (Diluted EPS) is --. EPS = Net Income / Total Diluted Shares, which is a key metric for measuring a company's profitability.

Q: Should you buy or sell AKESO 09926.HK (AKESO) now?

As of now, AKESO is trading at $91, with a P/E ratio of -67.638 and a diluted EPS of --. Your buy or sell decisions should be based on your investment goals and risk tolerance. We recommend making an overall judgment by considering AKESO 09926.HK's financial reports, the outlook of the -- sector, and your own holdings. Investing involves risk—please make decisions prudently.

Q: What factors can affect the stock price of AKESO 09926.HK (AKESO)?

Key factors include: company quarterly reports (revenue, EPS), competition and trends in the -- sector, macroeconomic environment (interest rate, inflation), market sentiment, as well as major events like product releases and mergers & acquisitions.

Q: How to buy AKESO 09926.HK (AKESO) stock?

You can buy AKESO 09926.HK (AKESO) through Gate. Sign up for a Gate account and complete identity verification, then go to the AKESO 09926.HK trading page to make a purchase. Gate supports fractional share trading, so you can start investing without buying a whole share.

$12.00

+$0.04(+0.38%)

*Data last updated: 2026-08-19 00:21 (UTC+8)

As of 2026-08-19 00:21, AKESO 09926.HK (AKESO) is priced at $12.00, with a total market cap of $10.62B, a P/E ratio of -67.63, and a dividend yield of 0.00%. Today, the stock price fluctuated between $11.16 and $11.66. The current price is 3.98% above the day's low and 0.49% below the day's high, with a trading volume of 889.23M. Over the past 52 weeks, AKESO has traded between $10.20 to $20.40, and the current price is -43.05% away from the 52-week high.

Key Stats

Yesterday's Close$11.56

Market Cap$10.62B

Volume889.23M

P/E Ratio-67.63

Dividend Yield (TTM)0.00%

Net Income (FY)-$145.44M

Shares Outstanding921.14M

Introduction

Akeso, Inc. is a biopharmaceutical company dedicated to the research, development, production, and commercialization of innovative antibody drugs that are affordable for patients worldwide. Since its inception, the company has built a unique end-to-end comprehensive new drug research and development platform, establishing an innovative R&D system centered on Tetrabody bispecific antibody development technology, antibody-drug conjugate (ADC) technology, T-cell engager (TCE) technology, siRNA/mRNA technology, and cell therapy technology, as well as an internationally standardized GMP production system and a mature commercialization system, becoming a competitive biomedical innovation company globally. As of now, the company has a total of over 50 innovative projects in development, covering multiple fields including oncology, autoimmune diseases, metabolic diseases, neurodegenerative diseases, and others. Seven self-developed products have been approved for marketing, namely Cadonilimab (PD-1/CTLA-4, trade name: Kaitanni), Ivonescimab (PD-1/VEGF, trade name: Yidafang), Penpulimab (PD-1, trade name: Annike), Inusimab (PCSK9, trade name: Yixining*), Ebdarokimab (IL-12/IL-23, trade name: Aidaluo), as well as Putelimab (PD-1, trade name: Puyouheng) licensed to Lepu Biopharma Co., Ltd. (stock code: 2157.HK) and Tagolimab (PD-L1, trade name: Ketailai) licensed to Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. Three products covering four new drug applications/new indication applications are under review by the NMPA. The company's overseas partner SUMMIT has submitted the first indication application for Ivonescimab, which has been accepted by the U.S. Food and Drug Administration (FDA). The company has a total of 27 products in the approved/clinical research stage, with 12 products in Phase III clinical trials and 15 products in Phase I/II clinical trials. Among the pipeline products, 18 are first-in-class or potentially first-in-class bispecific/multispecific antibodies, ADCs, and other innovative mechanism drugs. The company's vision is to become a globally leading biopharmaceutical enterprise by focusing on the research and development of innovative drugs, establishing internationally standardized production systems, and building a diversified business landscape.

CEO夏瑜

Official Websitehttp://www.akesobio.com

Employees (FY)3.76K

Market Cap Change (1Y)+0.23%

Average Revenue (1Y)$812.62K

Net Income per Employee-$303.32K

AKESO FAQ

What's the stock price of AKESO 09926.HK (AKESO) today?

x

AKESO 09926.HK (AKESO) is currently trading at $12.00, with a 24h change of +0.38%. The 52-week trading range is $10.20–$20.40.

What are the 52-week high and low prices for AKESO 09926.HK (AKESO)?

x

What is the price-to-earnings (P/E) ratio of AKESO 09926.HK (AKESO)? What does it indicate?

x

What is the market cap of AKESO 09926.HK (AKESO)?

x

What is the most recent quarterly earnings per share (EPS) for AKESO 09926.HK (AKESO)?

x

Should you buy or sell AKESO 09926.HK (AKESO) now?

x

What factors can affect the stock price of AKESO 09926.HK (AKESO)?

x

How to buy AKESO 09926.HK (AKESO) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

AKESO 09926.HK Price